SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-059358
Filing Date
2021-11-15
Accepted
2021-11-15 16:10:27
Documents
13
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea150252-8k_virpaxpharma.htm   iXBRL 8-K 26514
2 PRESS RELEASE OF VIRPAX PHARMACEUTICALS, INC. ISSUED NOVEMBER 15, 2021 ea150252ex99-1_virpaxpharma.htm EX-99.1 85121
  Complete submission text file 0001213900-21-059358.txt   299778

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vrpx-20211115.xsd EX-101.SCH 3037
4 XBRL LABEL FILE vrpx-20211115_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE vrpx-20211115_pre.xml EX-101.PRE 22367
6 EXTRACTED XBRL INSTANCE DOCUMENT ea150252-8k_virpaxpharma_htm.xml XML 3727
Mailing Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380 484-875-3195
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40064 | Film No.: 211410599
SIC: 2834 Pharmaceutical Preparations